Brief: Avanos Medical, Inc. Reports Preliminary Q4 And FY2023 Financial Results Revises Preliminary 2024 Revenue Outlook

Avanos Medical

04/01/2024 13:53

Jan 4 (Reuters) - Avanos Medical Inc  AVNS.N :
    * SAYS FOR Q4 ENDED DECEMBER 31, 2023, AVANOS MEDICAL
EXPECTS NET
SALES IN RANGE OF $170 MILLION TO $173 MILLION
    * REPORTS PRELIMINARY FOURTH QUARTER AND FULL-YEAR 2023
FINANCIAL
RESULTS; REVISES PRELIMINARY 2024 REVENUE OUTLOOK
    * FOR 2024, COMPANY NOW EXPECTS NET SALES IN RANGE OF $685
MILLION
TO $705 MILLION
    * SEES LOWER THAN EXPECTED NET SALES WILL NEGATIVELY IMPACT
ADJUSTED GROSS MARGIN, ADJUSTED EBITDA MARGIN AND ADJUSTED EPS
FOR Q4 AND FY

Source text for Eikon:  ID:nPn1Jvlhja 
Further company coverage:  AVNS.N 

 ((Reuters.Briefs@thomsonreuters.com;))